Literature DB >> 2348739

Vocal changes in patients undergoing radiation therapy for glottic carcinoma.

S Miller1, L B Harrison, B Solomon, R B Sessions.   

Abstract

A prospective evaluation of vocal changes in patients receiving radiation therapy for T1 and T2 (AJC) glottic carcinoma was undertaken in January 1987. Vocal analysis was performed prior to radiotherapy and at specific intervals throughout the radiation treatment program. The voicing ratio was extrapolated from a sustained vowel phonation using the Visipitch interfaced with the IBM-PC. Preliminary observations suggested three distinct patterns of vocal behavior: 1. reduced voicing ratio with precipitous improvement within the course of treatment, 2. high initial voicing ratio with reduction secondary to radiation induced edema, with rapid improvement in the voicing component after the edema subsided, and 3. fluctuating voicing ratio during and following treatment. Enrollment of new patients and a 2-year follow-up of current patients was undertaken.

Entities:  

Mesh:

Year:  1990        PMID: 2348739     DOI: 10.1288/00005537-199006000-00010

Source DB:  PubMed          Journal:  Laryngoscope        ISSN: 0023-852X            Impact factor:   3.325


  4 in total

1.  Quantitative analysis of voice quality in early glottic laryngeal carcinomas treated with radiotherapy.

Authors:  A S Dagli; H F Mahieu; J M Festen
Journal:  Eur Arch Otorhinolaryngol       Date:  1997       Impact factor: 2.503

2.  Vocal changes following radiotherapy to the head and neck for non-laryngeal tumors.

Authors:  Abdul-Latif Hamdan; Fadi Geara; Charbel Rameh; Sami Tanbouzi Husseini; Toufic Eid; Nabil Fuleihan
Journal:  Eur Arch Otorhinolaryngol       Date:  2009-03-25       Impact factor: 2.503

Review 3.  Effects of chemoradiotherapy on voice and swallowing.

Authors:  Cathy L Lazarus
Journal:  Curr Opin Otolaryngol Head Neck Surg       Date:  2009-06       Impact factor: 2.064

4.  Acoustic voice analysis in different phonetic contexts after larynx radiotherapy for T1 vocal cord carcinoma.

Authors:  Angeles Rovirosa; Carlos Ascaso; Rosa Abellana; Eugenio Martínez-Celdrán; Alicia Ortega; Mercedes Velasco; Montserrat Bonet; Teresa Herrero; Meritxell Arenas; Albert Biete
Journal:  Clin Transl Oncol       Date:  2008-03       Impact factor: 3.405

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.